[1]
|
Di Pasquale, M.F., Sotgiu, G., Gramegna, A., et al. (2019) Prevalence and Etiology of Community-Acquired Pneumonia in Immunocompromised Patients. Clinical Infectious Diseases, 68, 1482-1493. https://doi.org/10.1093/cid/ciy723
|
[2]
|
Van de Louw, A., Mirouse, A., Peyrony, O., Lemiale, V. and Azoulay, E. (2019) Bacterial Pneumonias in Immunocompromised Patients. Seminars in Respiratory and Critical Care Medicine, 40, 498-507.
https://doi.org/10.1055/s-0039-1696961
|
[3]
|
Rali, P., Veer, M., Gupta, N., et al. (2016) Opportunistic Pulmonary Infections in Immunocompromised Hosts. Critical Care Nursing Quarterly, 39, 161-175. https://doi.org/10.1097/CNQ.0000000000000109
|
[4]
|
Yang, L., He, D., Huang, D., Zhang, Z. and Liang, Z. (2022) Development and Validation of Nomogram for Hospital Mortality in Immunocompromised Patients with Severe Pneumonia in Intensive Care Units: A Single-Center, Retrospective Cohort Study. International Journal of General Medicine, 15, 451-463. https://doi.org/10.2147/IJGM.S344544
|
[5]
|
Aliberti, S., Dela Cruz, C.S., Amati, F., Sotgiu, G. and Restrepo, M.I. (2021) Community-Acquired Pneumonia. Lancet, 398, 906-919. https://doi.org/10.1016/S0140-6736(21)00630-9
|
[6]
|
Dalhoff, K., Marxsen, J. and Steinhoff, J. (2007) Pneumonien bei Immunsuppression. Der Internist, 48, 507-518.
https://doi.org/10.1007/s00108-007-1838-5
|
[7]
|
Pappas, P.G., Alexander, B.D., Andes, D.R., et al. (2010) Inva-sive Fungal Infections among Organ Transplant Recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clinical Infectious Diseases, 50, 1101-1111. https://doi.org/10.1086/651262
|
[8]
|
Pardo, E., Lemiale, V., Mokart, D., et al. (2019) Invasive Pulmonary Aspergillosis in Critically Ill Patients With Hematological Malignancies. Intensive Care Medicine, 45, 1732-1741. https://doi.org/10.1007/s00134-019-05789-6
|
[9]
|
(2009) Pneumonia in Immunocompromised Patients. Respirology, 14, S44-S50.
https://doi.org/10.1111/j.1440-1843.2009.01576.x
|
[10]
|
Hamilton, C.D. (2005) Immunosuppression Related to Collagen-Vascular Disease or Its Treatment. Proceedings of the American Thoracic Society, 2, 456-460. https://doi.org/10.1513/pats.200508-091JS
|
[11]
|
Brigden, M.L. and Pattullo, A.L. (1999) Prevention and Man-agement of Overwhelming Postsplenectomy Infection—An Update. Critical Care Medicine, 27, 836-842. https://doi.org/10.1097/00003246-199904000-00050
|
[12]
|
瞿介明. 免疫妥协宿主肺部感染——我国免疫抑制患者肺部感染诊治困惑及其剖析[J]. 中国实用内科杂志, 2009, 29(8): 685-686.
|
[13]
|
Azoulay, E., Pickkers, P., Soares, M., et al. (2017) Acute Hypoxemic Respiratory Failure in Immunocompromised Patients: The Efraim Multina-tional Prospective Cohort Study. Intensive Care Medicine, 43, 1808-1819.
https://doi.org/10.1007/s00134-017-4947-1
|
[14]
|
范思佳, 孙霓, 张永飞, 等. 恶性肿瘤化疗后肺部感染患者并发持续炎症-免疫抑制-分解代谢综合征的危险因素及预后分析[J]. 肿瘤研究与临床, 2019, 31(3): 172-175.
|
[15]
|
于婧, 宫小薇, 赵靖, 等. 非HIV免疫抑制患者合并重症肺炎的临床特点及预后因素[J]. 国际呼吸杂志, 2019, 39(19): 1467-1474.
|
[16]
|
Grover, S.B., Grover, H., Antil, N., et al. (2022) Imaging Approach to Pulmonary Infections in the Immunocompromised Patient. The Indian Journal of Radiology & Imaging, 32, 81-112. https://doi.org/10.1055/s-0042-1743418
|
[17]
|
Azoulay, E., Russell, L., Van de Louw, A., et al. (2020) Diagnosis of Severe Respiratory Infections in Immunocompromised Patients. Intensive Care Medicine, 46, 298-314. https://doi.org/10.1007/s00134-019-05906-5
|
[18]
|
Nachiappan, A.C., Rahbar, K., Shi, X., et al. (2017) Pulmonary Tuberculosis: Role of Radiology in Diagnosis and Management. Radiographics, 37, 52-72. https://doi.org/10.1148/rg.2017160032
|
[19]
|
Lletí, M.S., Navalón, M.D.C., Pitarch, M.T. and García-Bustos, V. (2022) Etiology, Diagnosis, and Management of Pneumonia in Immunosuppressed Patients. Revista Espanola de Quimioterapia, 35, 89-96.
https://doi.org/10.37201/req/s01.20.2022
|
[20]
|
中国医师协会急诊医师分会. 中国急诊重症肺炎临床实践专家共识[J]. 中国急救医学, 2016, 36(2): 97-107.
|
[21]
|
瞿介明, 何礼贤. 免疫抑制患者并发肺结核的诊断探讨[J]. 上海医科大学学报, 1994, 21(1): 23-26.
|
[22]
|
徐翠萍, 张波. 支气管肺泡灌洗在免疫抑制患者肺部感染中的诊断价值[J]. 国际呼吸杂志, 2014, 34(6): 455-460.
|
[23]
|
方余, 张频捷, 杨翔, 等. 支气管肺泡灌洗液G试验及GM试验对侵袭性肺部真菌感染的早期诊断价值[J]. 中国急救医学, 2019, 39(9): 827-831.
|
[24]
|
Acosta, J., Catalan, M., Del Palacio-Peréz-Medel, A., et al. (2011) A Prospective Comparison of Galactomannan in Bronchoalveolar Lavage Fluid for the Diagnosis of Pulmonary Invasive Aspergillosis in Medical Patients under Intensive Care: Comparison With the Diagnostic Performance of Galactomannan and of (1→3)-β-d-Glucan Chromogenic Assay in Serum Samples. Clinical Microbiology and Infection, 17, 1053-1060.
https://doi.org/10.1111/j.1469-0691.2010.03357.x
|
[25]
|
Shen, B., Yi, X., Sun, Y., et al. (2020) Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell, 182, 59-72. https://doi.org/10.1016/j.cell.2020.05.032
|
[26]
|
Walter, J.M. and Wunderink, R.G. (2018) Testing for Respiratory Viruses in Adults With Severe Lower Respiratory Infection. CHEST, 154, 1213-1222. https://doi.org/10.1016/j.chest.2018.06.003
|
[27]
|
Agustí, C., Rañó, A., Filella, X., et al. (2003) Pulmonary Infil-trates in Patients Receiving Long-Term Glucocorticoid Treatment: Etiology, Prognostic Factors, and Associated In-flammatory Response. CHEST, 123, 488-498.
https://doi.org/10.1378/chest.123.2.488
|
[28]
|
Li, L., Hsu, S.H., Gu, X., et al. (2020) Aetiology and Prognostic Risk Factors of Mortality in Patients With Pneumonia Receiving Glucocorticoids Alone or Glucocorticoids and Other Immunosuppressants: A Retrospective Cohort Study. BMJ Open, 10, e037419. https://doi.org/10.1136/bmjopen-2020-037419
|
[29]
|
何权瀛, 张波. 应高度重视免疫功能低下患者的肺部感染[J]. 中华结核和呼吸杂志, 2010, 33(10): 721-722.
|
[30]
|
Qureshi, S., Pandey, A., Sirohi, T.R., et al. (2014) Mixed Pulmonary Infection in an Immunocompromised Patient: A Rare Case Report. Indian Journal of Medical Microbiology, 32, 79-81. https://doi.org/10.4103/0255-0857.124330
|
[31]
|
王军. 无创呼吸机联合有创机械通气治疗呼吸衰竭的效果观察[J]. 基层医学论坛, 2020, 24(2): 182-183.
|
[32]
|
李蕾, 闫登峰. 有创-无创序贯机械通气在重症肺炎治疗中的应用[J]. 江苏医药, 2016, 42(4): 464-465.
|